The implications of B.1.617.2 (Delta)
Disclaimer: Asian Century Stocks uses information sources believed to be reliable, but their accuracy cannot be guaranteed. The information contained in this publication is not intended to constitute individual investment advice and is not designed to meet your personal financial situation. The opinions expressed in such publications are those of the publisher and are subject to change without notice. You are advised to discuss your investment options with your financial advisers. Consult your financial adviser to understand whether any investment is suitable for your specific needs. I may from time to time have positions in the securities covered in the articles on this website. This is disclosure and not a recommendation to buy or sell.
The SARS-CoV-2 variant B.1.617.2 that was first detected in India is likely to become a global problem.
There are two key issues with B.1.617.2:
Vaccination doesn’t completely halt the COVID-19 disease progression
It can lead to symptomatic infection in…
Keep reading with a 7-day free trial
Subscribe to Asian Century Stocks to keep reading this post and get 7 days of free access to the full post archives.